These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 794716)

  • 1. Comparison of two naltrexone treatment programs: naltrexone alone versus naltrexone plus behavior therapy.
    Callahan E; Rawson R; Glazer M; McCleave B; Arias R
    NIDA Res Monogr; 1976 Sep; (9):150-7. PubMed ID: 794716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone in methadone maintenance patients electing to become "drug free".
    Haas N; Ling W; Holmes E; Blakis M; Litaker M
    NIDA Res Monogr; 1976 Sep; (9):70-3. PubMed ID: 794723
    [No Abstract]   [Full Text] [Related]  

  • 3. Factors influencing success in an antagonistic treatment program.
    Parwatikar S; Crawford J; Nelkupa JV; De Gracia C
    NIDA Res Monogr; 1976 Sep; (9):77-81. PubMed ID: 794725
    [No Abstract]   [Full Text] [Related]  

  • 4. Experiences with Naltrexone in Buffalo.
    Taintor Z; Landsberg R; Wicks N
    Am J Drug Alcohol Abuse; 1975; 2(3-4):391-401. PubMed ID: 775969
    [No Abstract]   [Full Text] [Related]  

  • 5. NIDA's naltrexone research program.
    Julius D
    NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
    [No Abstract]   [Full Text] [Related]  

  • 6. Narcotic antagonists: naltrexone progress report: introduction.
    Renault PF
    NIDA Res Monogr; 1976 Sep; (9):1-3. PubMed ID: 794713
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical use of naltrexone (EN 1639 A). Part II: experience with the first 50 patients in a New York City treatment clinic.
    Schecter A
    Am J Drug Alcohol Abuse; 1975; 2(3-4):433-42. PubMed ID: 1227301
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient response to naltrexone: issues of acceptance, treatment effects, and frequency of administration.
    Curran S; Savage C
    NIDA Res Monogr; 1976 Sep; (9):67-9. PubMed ID: 794722
    [No Abstract]   [Full Text] [Related]  

  • 9. Naltrexone and behavior therapy for heroin addiction.
    Rawson RA; Glazer M; Callahan EJ; Liberman RP
    NIDA Res Monogr; 1979 Jun; (25):26-43. PubMed ID: 117373
    [No Abstract]   [Full Text] [Related]  

  • 10. Short-term effects of naltrexone in 155 heroin ex-addicts.
    Volavka J; Resnick RB; Kestenbaum RS; Freedman AM
    Biol Psychiatry; 1976 Dec; 11(6):679-85. PubMed ID: 999987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of contingent payment on compliance with a naltrexone regimen.
    Grabowski J; O'Brien CP; Greenstein R; Ternes J; Long M; Steinberg-Donato S
    Am J Drug Alcohol Abuse; 1979; 6(3):355-65. PubMed ID: 539577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of the National Academy of Sciences study of naltrexone.
    Kaim SC
    NIDA Res Monogr; 1976 Sep; (9):37-44. PubMed ID: 794719
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
    Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
    Rawson RA; Tennant FS
    NIDA Res Monogr; 1984 Mar; 49():289-95. PubMed ID: 6434974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varying clinical contexts for administering naltrexone.
    Hurzeler M; Gerwirtz D; Kleber H
    NIDA Res Monogr; 1976 Sep; (9):48-66. PubMed ID: 794721
    [No Abstract]   [Full Text] [Related]  

  • 16. Narcotic antagonist treatment: clinical experience with naltrexone.
    Lewis DC; Mayer J; Hersch RG; Black R
    Int J Addict; 1978 Aug; 13(6):961-73. PubMed ID: 730406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison.
    Judson BA; Carney TM; Goldstein A
    Drug Alcohol Depend; 1981 Jul; 7(4):325-46. PubMed ID: 7023894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with naltrexone.
    O'Brien CP; Greenstein RA; Mintz J; Woody GE
    Am J Drug Alcohol Abuse; 1975; 2(3-4):365-77. PubMed ID: 1227298
    [No Abstract]   [Full Text] [Related]  

  • 19. The treatment of heroin addiction: naltrexone alone and with behavior therapy.
    Callahan EJ; Rawson RA; McCleave B; Arias R; Glazer M; Liberman RP
    Int J Addict; 1980 Aug; 15(6):795-807. PubMed ID: 7461877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.